Skip to Content

Join the 'Asthma' group to help and get support from people like you.

Asthma News

Related terms: Bronchial Asthma, Exercise-induced asthma, Wheezing

Managing Allergies, Asthma 101

Posted 2 days ago by Drugs.com

TUESDAY, May 3, 2016 – Teens with allergies or asthma who are heading for college later this year should begin preparing for the transition now, an expert says. "For most teens, going away to college marks their first time living independently," said Dr. David Stukus, a member of the American College of Allergy, Asthma and Immunology Public Relations Committee. "In addition to moving to a new place, many must learn to manage their own schedule, diet, exercise and health. Young people may find their allergies and asthma neglected due to other, seemingly more important demands on their attention," he said in a college news release. Stukus offers tips on how teens with allergies or asthma can prepare for college in an article published May 3 in the journal Annals of Allergy, Asthma and Immunology. The first step, he said, is to meet with your allergist and: Review your asthma and/or ... Read more

Related support groups: Allergic Reactions, Allergies, Asthma, Asthma - Maintenance, Allergic Rhinitis, Hay Fever, Asthma - Acute, Anaphylaxis, Allergic Asthma, Reversible Airways Disease, Reversible Airways Disease - Maintenance

Teva Announces FDA Approval of ProAir RespiClick (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11

Posted 2 days 20 hours ago by Drugs.com

JERUSALEM--(BUSINESS WIRE)--Apr. 29, 2016-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol sulfate) Inhalation Powder for the treatment or prevention of bronchospasm in children 4 to 11 years of age with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm (EIB). ProAir RespiClick was approved by the FDA for use in patients 12 years of age and older in March 2015 and remains the only breath-activated, multi-dose, dry powder, short-acting beta-agonist (SABA) inhaler available in the U.S. “The prevalence of childhood asthma in the U.S. is high, at more than six million patients, and that number continues to rise,” said Dr. Erwin Gelfand, Chairman, Department of Pediatrics at National Jewish Health. “For this young population of as ... Read more

Related support groups: Asthma, Albuterol, Asthma - Acute, ProAir RespiClick

More U.S. Kids Have Chronic Health Problems: Study

Posted 4 days ago by Drugs.com

SATURDAY, April 30, 2016 – The number of American kids suffering from asthma and attention deficit hyperactivity disorder (ADHD) is on the increase, with poor children being hit the hardest, researchers report. Children living in extreme poverty who had asthma and ADHD were nearly twice as likely to have at least one other chronic medical condition. These conditions included developmental delays, autism, depression, anxiety, behavioral or conduct issues, speech and language problems, epilepsy and other seizure disorders, and learning disabilities. "These findings emphasize the importance of studying poverty and its impact on child health, as well as confirm the need for increased awareness to inform child health policy," said lead researcher Dr. Christian Pulcini, a resident at Children's Hospital of Pittsburgh. The reasons for the increase in chronic conditions aren't clear, but ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Attention Deficit Hyperactivity Disorder (ADHD), Asthma, Major Depressive Disorder, Asthma - Maintenance, Oppositional Defiant Disorder, Autism, Asthma - Acute, Dysthymia

Climate Change May Mean More Smoggy Days to Come: Study

Posted 14 days ago by Drugs.com

THURSDAY, April 21, 2016 – Climate change could cause many major American cities to experience more days with heavy ozone pollution in the coming decades, a new study predicts. If emission rates continue unchecked, regions within the United States could experience between three and nine additional days of unhealthy ozone levels between May and September by 2050, the study authors said. The researchers are concerned that climate change could undo the progress made under the Clean Air Act to rid U.S. skies of air pollution. "We found, in fact, that climate change could be a monkey wrench in our plans," said study co-author Loretta Mickley. She is a senior research fellow at Harvard's School of Engineering and Applied Sciences in Cambridge, Mass. "The number of bad ozone days per summer could double – could increase by as much as a week – by the 2050s," she said. California, the ... Read more

Related support groups: Cough, Asthma, Sinusitis, Chronic Obstructive Pulmonary Disease, Bronchitis, Pneumonia, Cold Symptoms, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Asthma - Acute, Cough and Nasal Congestion, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Allergic Asthma, Croup, Bronchospastic Disease

National Prescription Drug Take-Back Day Set For April 30th

Posted 17 days ago by Drugs.com

Event will take place from 10 am to 2 pm on Saturday, April 30th On Saturday, April 30th, 2016 from 10:00 am – 2:00 pm local time, communities will team up with law enforcement to host the 11th National Prescription Drug Take-Back Day. You can call the Drug Enforcement Agency's (DEA's) Registration Call Center at 1-800-882-9539 or check the DEA's website for collection sites in your area. The website will be continuously updated with new take-back locations. DEA began hosting National Prescription Drug Take-Back events in 2010. At the previous 10 Take-Back Day events, over 5.5 million pounds of unwanted, unneeded or expired medications were surrendered for safe and proper disposal. The disposal service is free and anonymous for consumers, with no questions asked. Keep in mind that needles, sharps, asthma inhalers, and illicit drugs are not accepted at the drop box. Prescription m ... Read more

Related support groups: Diabetes, Type 2, Cancer, Metoprolol, Asthma, Atenolol, Propranolol, Bystolic, Carvedilol, Bisoprolol, Coreg, Inderal, Sotalol, Fluticasone, Toprol-XL, Qvar, Lopressor, Nitroglycerin, Imdur, Timolol, Flovent

Doctors Issue Call to Combat Climate Change

Posted 17 days ago by Drugs.com

MONDAY, April 18, 2016 – Climate change is already harming people's health by promoting illnesses linked to warmer temperatures and changing weather patterns, a leading group of U.S. doctors says in a new position paper. As a result, the American College of Physicians (ACP) is calling for "aggressive, concerted" action to fight climate change by curbing man-made greenhouse gas emissions. Respiratory illnesses, heat stroke and infectious diseases like Zika virus, dengue fever and cholera are flourishing as global temperatures rise, said Dr. Wayne Riley, president of the college. "Our climate is already changing and people are already being harmed. If we don't begin to address climate change, we're going to see more and more manifestations of these health problems," Riley said. "There is clear, compelling scientific consensus that climate change is real," he added. "There is no dispute." ... Read more

Related support groups: Depression, Anxiety and Stress, Migraine, Allergies, Asthma, Major Depressive Disorder, Post Traumatic Stress Disorder, Sinusitis, Chronic Obstructive Pulmonary Disease, Migraine Prevention, Bronchitis, Pneumonia, Asthma - Maintenance, Cold Symptoms, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Dyspnea, Migraine Prophylaxis, Psychiatric Disorders, Asthma - Acute

Cinqair Approved for Severe Asthma

Posted 23 Mar 2016 by Drugs.com

WEDNESDAY, March 23, 2016 – Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older. The drug is to be used in combination with other medications, the agency noted. In a Wednesday news release, the agency said that more than 22 million people in the United States have asthma, which leads to more than 400,000 hospitalizations annually. Cinqair, given by injection every four weeks, is designed to reduce severe asthma attacks by reducing blood levels of eosinophils, a white blood cell that contributes to asthma, the FDA said. In clinical studies involving an unspecified number of severe asthma sufferers, people who took Cinqair had fewer severe attacks than those who took a placebo, and a longer time to the first attack, the agency said. Users of Cinqair, a lab-developed "interleukin-5 antagonist monoclonal ... Read more

Related support groups: Asthma, Asthma - Maintenance, Cinqair, Reslizumab

FDA Approves Cinqair (reslizumab) to Treat Severe Asthma

Posted 23 Mar 2016 by Drugs.com

March 23, 2016 – The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines. Asthma is a chronic disease that causes inflammation in the airways of the lungs. During an asthma attack, airways become narrow making it hard to breathe. Severe asthma attacks can lead to asthma-related hospitalizations because these attacks can be serious and even life-threatening. According to the Centers for Disease Control and Prevention, as of 2013, more than 22 million people in the U.S. have asthma, and there are more than 400,000 asthma-related hospitalizations each year. “Health care providers and their patients with severe a ... Read more

Related support groups: Asthma, Asthma - Maintenance, Cinqair, Reslizumab

MS Patients May Be Prone to Other Chronic Illnesses, Study Finds

Posted 9 Mar 2016 by Drugs.com

WEDNESDAY, March 9, 2016 – People with multiple sclerosis (MS) are more likely to have other chronic health problems than those without the nervous system disorder, a new study indicates. Researchers looked at how common several chronic conditions – high blood pressure, diabetes, high cholesterol, heart disease, chronic lung disease, epilepsy, fibromyalgia, inflammatory bowel disease, depression, anxiety, bipolar disorder and schizophrenia – were in nearly 23,400 people newly diagnosed with MS and more than 116,600 people without MS. The MS patients had higher rates of all the conditions, with high cholesterol being the exception. Their rates of mental illness, particularly depression, were also high. Nineteen percent of MS patients and 9 percent of those without MS had depression, the study found. For many of the chronic conditions, there were significant gender differences. High ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Seizures, Hypertension, Asthma, Heart Disease, Multiple Sclerosis, Chronic Obstructive Pulmonary Disease, Epilepsy, High Cholesterol, Heart Attack, Mania, Schizophrenia, Schizoaffective Disorder, Angina, Diabetic Neuropathy, Seizure Prevention, Upper Respiratory Tract Infection, Diabetic Nerve Damage, Insulin Resistance

Special Infant Formulas Don't Shield Against Asthma, Allergies: Study

Posted 9 Mar 2016 by Drugs.com

TUESDAY, March 8, 2016 – Many parents who worry that their baby is at risk of asthma, allergies or type 1 diabetes may turn to special cow's milk formulas touted to lower the risk. But a new review of the data on these "hydrolyzed" infant formulas finds no good evidence that they actually protect children from the autoimmune disorders. "We found no consistent evidence to support a protective role for partially or extensively hydrolyzed formula," concluded a team led by Robert Boyle of Imperial College London in England. "Our findings conflict with current international guidelines, in which hydrolyzed formula is widely recommended for young formula-fed infants with a family history of allergic disease," the study authors added. One expert in the United States said the finding casts doubt on the usefulness of these special formula products. "Allergies and autoimmune diseases [such as ... Read more

Related support groups: Allergic Reactions, Allergies, Asthma, Asthma - Maintenance, Allergic Rhinitis, Hay Fever, Asthma - Acute, Anaphylaxis, Allergic Asthma, Allergic Purpura, Reversible Airways Disease - Maintenance, Reversible Airways Disease

Poverty Linked to Asthma, Allergy Treatment Failure

Posted 8 Mar 2016 by Drugs.com

MONDAY, March 7, 2016 – People with asthma or food allergies who are poor have worse treatment outcomes, two new studies suggest. "We found that patients who have asthma and come from lower income households – making less than $50,000 every year – are one and a half times more likely to see treatment fail. They are also almost twice as likely to have an asthma exacerbation," study co-author Dr. Juan Carlos Cardet said in a news release from the American Academy of Allergy, Asthma & Immunology (AAAAI). Cardet, who is from Brigham and Women's Hospital in Boston, and his research team surveyed nearly 400 people with asthma. They found that lower income was strongly linked with poor treatment outcomes, regardless of race, stress and education levels. "Income is an independent risk factor for worse asthma outcomes," Cardet said. But the study did not show a cause-and-effect relationship ... Read more

Related support groups: Allergic Reactions, Asthma, Asthma - Maintenance, Asthma - Acute, Anaphylaxis, Allergic Asthma, Reversible Airways Disease, Reversible Airways Disease - Maintenance

Traffic Pollution Tied to Preterm Birth Risk for Asthmatic Women

Posted 1 Mar 2016 by Drugs.com

TUESDAY, March 1, 2016 – Exposure to high levels of certain traffic air pollutants may increase the risk of preterm birth in pregnant women with asthma, a new study suggests. Both short- and long-term exposure to pollution from vehicles was linked to a higher risk of preterm birth in women with asthma. This was especially true when women were exposed to pollutants just before conceiving, in early pregnancy and the last six weeks of pregnancy, the study found. "Preterm birth is a major public health problem in this country, affecting more than one in 10 infants born in the United States," said study author Pauline Mendola, an investigator at the U.S. National Institute of Child Health and Human Development. Preterm birth is considered to be a birth before 37 weeks of pregnancy. "Our study found that air pollution appears to add to the preterm birth risk faced by women with asthma. These ... Read more

Related support groups: Asthma, Asthma - Maintenance, Asthma - Acute, Premature Labor, Allergic Asthma, Prematurity/Underweight in Infancy, Reversible Airways Disease, Reversible Airways Disease - Maintenance

Women With Asthma May Be Prone to Fertility Problems: Study

Posted 13 Feb 2016 by Drugs.com

FRIDAY, Feb. 12, 2016 – Women with asthma may take longer to get pregnant and have a lower pregnancy rate than those without the lung disease, new research suggests. The study included 245 women, aged 23 to 45, who had unexplained fertility problems and were undergoing fertility treatment. Ninety-six of the women had been diagnosed with asthma. The women were followed until they had a successful pregnancy, stopped treatment or the study ended. The median time for women without asthma to get pregnant was about 32 months compared to more than 55 months for those with asthma. Median means half took more time to conceive; half, less. About 60 percent of women without asthma got pregnant, compared with just under 40 percent of those with asthma, the findings showed. The gap between the two groups increased with age, according to the study published Feb. 12 in the European Respiratory ... Read more

Related support groups: Asthma, Female Infertility

Asthma May Raise Risk for Abdominal Aneurysm

Posted 12 Feb 2016 by Drugs.com

THURSDAY, Feb. 11, 2016 – People 50 and older who have had recent asthma activity appear to be at an increased risk of abdominal aortic aneurysm, a new study suggests. An abdominal aortic aneurysm is a weak spot in the body's main artery, the aorta, where it passes through the abdomen. That weak spot can rupture, causing massive bleeding. The researchers also found that people with recent asthma activity were more likely to have an aneurysm rupture compared to those without recent asthma activity. "People with abdominal aortic aneurysm who were diagnosed with asthma within the past year had more than a 50 percent greater risk of ruptured aneurysms than those without asthma," said lead researcher Guo-Ping Shi, from Brigham and Women's Hospital in Boston. Men diagnosed with asthma within the preceding six months were twice as likely to have an aortic aneurysm rupture, Shi said, adding ... Read more

Related support groups: Asthma, Aortic Aneurysm

Prenatal Acetaminophen Use Tied to Higher Asthma Risk in Kids: Study

Posted 10 Feb 2016 by Drugs.com

WEDNESDAY, Feb. 10, 2016 – Pregnant women who take the painkiller acetaminophen – best known under the brand name Tylenol – may be more likely to have a child with asthma, new research suggests. Although the study wasn't designed to prove cause-and-effect, researchers found that prenatal exposure to the over-the-counter medicine was associated with an increased risk for asthma in children. However, the study authors and a U.S. expert agreed that the effect seen in the study doesn't yet warrant any change in guidelines regarding pain relief during pregnancy. In the study, Norwegian researchers tracked data from a large database – the Norwegian Mother and Child Cohort Study. The investigators focused on conditions during pregnancy for which some expectant mothers took acetaminophen, and compared that data against rates of asthma among 114,500 children as they reached the ages of 3 and ... Read more

Related support groups: Birth Control, Contraception, Percocet, Vicodin, Emergency Contraception, Norco, Lortab, Asthma, Tylenol, Influenza, Acetaminophen, Asthma - Maintenance, Cold Symptoms, Paracetamol, Fioricet, Postcoital Contraception, Female Infertility, Excedrin, Endocet, Darvocet-N 100

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Asthma - Maintenance, Asthma - Acute, Allergic Asthma, Reversible Airways Disease, Respiratory Tract Disease

Related Drug Support Groups

prednisone, methylprednisolone, Singulair, caffeine, dexamethasone, Medrol, triamcinolone, montelukast, Xopenex, view more... Dulera, Decadron, evening primrose, ipratropium, Bronchial, Atrovent, Solu-Medrol, Primrose Oil, Evening Primrose Oil, Breo Ellipta, Medrol Dosepak, Alvesco, Depo-Medrol, MethylPREDNISolone Dose Pack, feverfew, Kenalog-40, Atrovent HFA, Deltasone, Azmacort, Aerobid, Nucala, flunisolide, levalbuterol, Dyflex-G, Bronkometer, Liquid Pred, Sterapred DS, Dy-G, Dexpak Taperpak, Adrenocot, Dexone, Aerospan, Xopenex HFA, isoetharine, guaifenesin / theophylline, Ipratropium Inhalation Solution, A-methapred, Adrenocot LA, Aerobid-M, Sterapred, Equibron G, Theo G, Decaject LA, Decaject, Theophyll-GG, Dyphyl GG, Difil G, Dyphylline GG, Solu-Phyllin GG, Ed-Bron G, Dalalone LA, Quibron-300, Cinqair, Glyceryl T, Slo-Phyllin GG, Asbron G, Uni Bronchial, Rayos, Theocon, Difil-G Forte, Theolate, Zema Pak, Broncomar GG, Dilor-G, Theomax DF, Quadrinal, Marax DF, Hydroxy Compound, Ami-rax, Broncodur, Baycadron, Dexamethasone Intensol, Bronkosol, Dilor-400, Xopenex Concentrate, Hydrophed, Ipratropium Inhalation Aerosol, Dyfilin GG, Dyphyllin-GG, Dalalone, Dalalone DP, Panfil G, Tedrigen, Dilex-G 400, Marax, Theodrine, Jay-Phyl, Dilex-G 200, Dyline GG, M-Prednisolone, Theomar GG, Hexadrol, Elixophyllin-GG, Quibron, Dilor, Lufyllin, Decadron-LA, Solurex LA, Dexasone, Dexasone LA, Dexacort-LA, De-Sone LA, Dexacen-4, Solurex, Dilex-G, Lufyllin-GG, ephedrine / phenobarbital / theophylline, oxtriphylline, ephedrine / phenobarbital / potassium iodide / theophylline, ephedrine / hydroxyzine / theophylline, dyphylline, dyphylline / guaifenesin, black haw, ciclesonide, reslizumab, Dylix, mepolizumab, fluticasone / vilanterol, formoterol / mometasone, Dexone LA, Primethasone, Methylcotolone, Methylpred DP, Methacort 80, Methacort 40, Predacorten, Med-Jec-40, Meticorten, Orasone, Choledyl SA, Neothylline, Choledyl, Prednicot, Prednicen-M, Methylcotol, Medralone 80, Dep Medalone 80, Depoject-80, Depopred, Medidex LA, Dexacorten, Medidex, Adlone-40, Adlone-80, Medralone, Medralone 40, Medipred, Duralone, Depmedalone, Lufyllin-400